Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.

Original publication

DOI

10.1038/nchembio0709-436

Type

Journal article

Journal

Nat Chem Biol

Publication Date

07/2009

Volume

5

Pages

436 - 440

Keywords

Animals, Biomedical Research, Clinical Trials as Topic, Cooperative Behavior, Drug Discovery, Drug Evaluation, Drug Industry, Humans, Molecular Probes